Warum ich Anteile an Ontrak kaufe?
eröffnet am 21.10.20 07:44:35 von
neuester Beitrag 01.03.24 09:56:04 von
neuester Beitrag 01.03.24 09:56:04 von
Beiträge: 110
ID: 1.332.684
ID: 1.332.684
Aufrufe heute: 0
Gesamt: 8.132
Gesamt: 8.132
Aktive User: 0
ISIN: US6833733024 · WKN: A3EJLV · Symbol: HY10
0,2730
EUR
+0,18 %
+0,0005 EUR
Letzter Kurs 29.04.24 Tradegate
Neuigkeiten
16.04.24 · Business Wire (engl.)  |
03.04.24 · Business Wire (engl.) |
21.03.24 · Business Wire (engl.) |
14.03.24 · Business Wire (engl.) |
12.03.24 · Business Wire (engl.) |
Werte aus der Branche Gesundheitswesen
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 4,9700 | +324,79 | |
| 1,7400 | +74,00 | |
| 0,6755 | +30,15 | |
| 0,5600 | +22,57 | |
| 2,2520 | +20,11 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,5480 | -12,74 | |
| 0,5570 | -15,31 | |
| 0,5700 | -16,60 | |
| 0,5325 | -20,53 | |
| 1,8819 | -55,93 |
Beitrag zu dieser Diskussion schreiben
Feedback
Es kommen nun zwar vermehrt News rein, heute zur Kooperation mit Sentara Health, aber an der Aktie geht das mittlerweile komplett vorbei.
Und in Kurzfassung zur Kapitalerhöhung. Ganz frisch im November initiiert: 5,5 Mio. USD zu 0,6 USD / Aktie eingesammelt. Ordentliche Verwässerung, kein Wunder, dass der Kurs auf diesem Stand erstmal zementiert ist.
Zudem gibt es noch einen Haufen Optionen mit Ausübungspreis 0,85 USD. Da dürfte mit Blick nach oben kurstechnisch rein theoretisch dann erstmal ein gewisser Deckel liegen.
Zielumsatz 2023 von 12 bis 14 Mio. USD bestätigt.
Hier noch die Quelle zu den Kapitalmaßnahmen: https://ontrakhealth.com/investors/press-releases/?qmodStory…
"On November 14, 2023, the Company announced the closing of its previously announced public offering of:
4,592,068 shares of its common stock and 9,184,136 warrants to purchase up to 9,184,136 shares of its common stock at a combined public offering price of $0.60 per share of common stock and accompanying warrants, and
5,907,932 pre-funded warrants to purchase up to 5,907,932 shares of its common stock and 11,815,864 warrants to purchase up to 11,815,864 shares of its common stock at a combined public offering price of $0.5999 per pre-funded warrant and accompanying warrants, which represents the per share public offering price for the common stock and accompanying warrants less the $0.0001 per share exercise price for each pre-funded warrant.
The Company estimates net proceeds of approximately $5.5 million from the public offering described above.
In addition, concurrent with the public offering described above, the Company announced the closing of its previously announced concurrent private placement (the “Private Placement”) of $11.0 million worth of unregistered pre-funded warrants to purchase shares of the Company's common stock and unregistered warrants to purchase shares of the Company's common stock to Acuitas. The Company issued 18,333,333 pre-funded warrants to purchase up to 18,333,333 shares of its common stock and 36,666,666 warrants to purchase up to 36,666,666 shares of its common stock at a purchase price of $0.5999 per pre-funded warrant and accompanying warrants, which represents the per share public offering price for the common stock and accompanying warrants less the $0.0001 per share exercise price for each pre-funded warrant. The warrants accompanying the pre-funded warrants have an exercise price of $0.85 per share. The exercisability of such warrants are subject to stockholder approval and, if such approval is obtained, will expire on the fifth anniversary of the date of such approval. The consideration for the Private Placement Securities purchased by Acuitas consisted of (a) the $6.0 million of escrowed funds then held in the escrow account, and (b) a reduction of the aggregate amounts outstanding under the Keep Well Notes (after giving effect to the Notes Conversion) to $2.0 million (the “Surviving Note”). Prior to the closing of the public offering and private placement, Acuitas converted approximately $16.3 million of outstanding senior secured convertible notes, leaving $2.0 million of Surviving Note."
Zudem gibt es noch einen Haufen Optionen mit Ausübungspreis 0,85 USD. Da dürfte mit Blick nach oben kurstechnisch rein theoretisch dann erstmal ein gewisser Deckel liegen.
Zielumsatz 2023 von 12 bis 14 Mio. USD bestätigt.
Hier noch die Quelle zu den Kapitalmaßnahmen: https://ontrakhealth.com/investors/press-releases/?qmodStory…
"On November 14, 2023, the Company announced the closing of its previously announced public offering of:
4,592,068 shares of its common stock and 9,184,136 warrants to purchase up to 9,184,136 shares of its common stock at a combined public offering price of $0.60 per share of common stock and accompanying warrants, and
5,907,932 pre-funded warrants to purchase up to 5,907,932 shares of its common stock and 11,815,864 warrants to purchase up to 11,815,864 shares of its common stock at a combined public offering price of $0.5999 per pre-funded warrant and accompanying warrants, which represents the per share public offering price for the common stock and accompanying warrants less the $0.0001 per share exercise price for each pre-funded warrant.
The Company estimates net proceeds of approximately $5.5 million from the public offering described above.
In addition, concurrent with the public offering described above, the Company announced the closing of its previously announced concurrent private placement (the “Private Placement”) of $11.0 million worth of unregistered pre-funded warrants to purchase shares of the Company's common stock and unregistered warrants to purchase shares of the Company's common stock to Acuitas. The Company issued 18,333,333 pre-funded warrants to purchase up to 18,333,333 shares of its common stock and 36,666,666 warrants to purchase up to 36,666,666 shares of its common stock at a purchase price of $0.5999 per pre-funded warrant and accompanying warrants, which represents the per share public offering price for the common stock and accompanying warrants less the $0.0001 per share exercise price for each pre-funded warrant. The warrants accompanying the pre-funded warrants have an exercise price of $0.85 per share. The exercisability of such warrants are subject to stockholder approval and, if such approval is obtained, will expire on the fifth anniversary of the date of such approval. The consideration for the Private Placement Securities purchased by Acuitas consisted of (a) the $6.0 million of escrowed funds then held in the escrow account, and (b) a reduction of the aggregate amounts outstanding under the Keep Well Notes (after giving effect to the Notes Conversion) to $2.0 million (the “Surviving Note”). Prior to the closing of the public offering and private placement, Acuitas converted approximately $16.3 million of outstanding senior secured convertible notes, leaving $2.0 million of Surviving Note."
Und hier jetzt noch die wichtige Passage zur Refinanzierung / Patronatserklärung mit dem Private-Equity-Akteur Acuitas Investments, LLC:
"On October 31, 2023, the Company and Acuitas Capital entered into a Fifth Amendment to the Master Note Purchase Agreement, as amended (the "Fifth Amendment"), which, among other things, amended the definition of Qualified Financing to replace $10.0 million with $8.0 million, and in the event the Company completes a Qualified Financing, as defined in the Keep Well Agreement, the following are provided: i) the conversion of Keep Well Notes plus accrued and unpaid interest thereon, less $7.0 million, ii) in lieu of the provision set forth in the Fourth Amendment concerning investment of Escrowed Funds in an offering (which is described below), the Company and Acuitas to consummate a private placement which would consist of the escrowed funds and $5.0 million of Keep Well Notes in pre-funded warrants. In addition, the maturity date of the remaining $2.0 million Keep Well Note was changed from September 30, 2024 to the date that is two years and six months after the closing date of the offering (May 14, 2026), unless it becomes due and payable in full earlier, whether by acceleration or otherwise."
"On October 31, 2023, the Company and Acuitas Capital entered into a Fifth Amendment to the Master Note Purchase Agreement, as amended (the "Fifth Amendment"), which, among other things, amended the definition of Qualified Financing to replace $10.0 million with $8.0 million, and in the event the Company completes a Qualified Financing, as defined in the Keep Well Agreement, the following are provided: i) the conversion of Keep Well Notes plus accrued and unpaid interest thereon, less $7.0 million, ii) in lieu of the provision set forth in the Fourth Amendment concerning investment of Escrowed Funds in an offering (which is described below), the Company and Acuitas to consummate a private placement which would consist of the escrowed funds and $5.0 million of Keep Well Notes in pre-funded warrants. In addition, the maturity date of the remaining $2.0 million Keep Well Note was changed from September 30, 2024 to the date that is two years and six months after the closing date of the offering (May 14, 2026), unless it becomes due and payable in full earlier, whether by acceleration or otherwise."
Ich habe dieses Statement vom Unternehmen gefunden:
"Company raises approximately $5.5 million, net in public offering of shares of Company's common stock and pre-funded warrants, completes $11.0 million concurrent private placement of unregistered pre-funded warrants and unregistered warrants to purchase shares of Company's common stock and $16.3 million conversion of secured notes"
"Company raises approximately $5.5 million, net in public offering of shares of Company's common stock and pre-funded warrants, completes $11.0 million concurrent private placement of unregistered pre-funded warrants and unregistered warrants to purchase shares of Company's common stock and $16.3 million conversion of secured notes"
Gerade mal die Neunmonatszahlen 2023 angeschaut
Umsatz: 9,2 Mio. USD
Verlust: 21,6 Mio. USD
"Eigene" Liquidität nur noch 3,2 Mio. USD. Dann halt noch die Zusagen im Rahmen der Patronatserklärung (8 Mio. USD, davon 6 Mio. USD treuhänderisch verwahrt). Damit dann ausgewiesene 9,2 Mio. USD Liquidität.
Hat jemand tiefergehende Einblicke / Erkenntnisse über die Finanzierungssituation?
Umsatz: 9,2 Mio. USD
Verlust: 21,6 Mio. USD
"Eigene" Liquidität nur noch 3,2 Mio. USD. Dann halt noch die Zusagen im Rahmen der Patronatserklärung (8 Mio. USD, davon 6 Mio. USD treuhänderisch verwahrt). Damit dann ausgewiesene 9,2 Mio. USD Liquidität.
Hat jemand tiefergehende Einblicke / Erkenntnisse über die Finanzierungssituation?
Trading Spotlight
…und immer noch dabei…bei den Kursen hast du ja schon 10000 Euro minus
…also ich habe nicht nachgekauft…das ist hier zu viel Spielcasino…
…also ich habe nicht nachgekauft…das ist hier zu viel Spielcasino…
Vielleicht hast du recht — ich hatte immer gehofft, dass die doch noch x
einen neuen Kunden präsentieren…leider ist das nicht geschehen…Frage mich was
passiert, wenn die FED die Zinsen wieder leicht senkt…da werden viele
profitieren aber ob das eine Mini Ontrak macht?
Die sind ja mit einer unglaublichen Marktkapitalisierung bewertet…und wenn die
jetzt an der nasdaq gedelisted werden…kein Vertrauensbeweis
einen neuen Kunden präsentieren…leider ist das nicht geschehen…Frage mich was
passiert, wenn die FED die Zinsen wieder leicht senkt…da werden viele
profitieren aber ob das eine Mini Ontrak macht?
Die sind ja mit einer unglaublichen Marktkapitalisierung bewertet…und wenn die
jetzt an der nasdaq gedelisted werden…kein Vertrauensbeweis
Gehe dabei von einem Buy-Out aus. Hoffe, dass sie ihr Ding gut machen, und sich nun schön dafür rausputzen.
Glaube die Voraussetzungen sind ok.
Glaube die Voraussetzungen sind ok.
Antwort auf Beitrag Nr.: 74.770.766 von suedama am 08.11.23 22:51:12Ja, und habe nochmal verbilligt, da ich an die Idee und so weiter glaube. Außerdem waren die letzten Zahlen sowie der Ausblick und das erwähnte Momentum im Sales und Marketing Bereich recht positiv. Turnaround ist eingeläutet.
Doch ich bin noch da…hast du deine 70000 Stück noch?
Das finde ich echt mutig…da habe ich nur ein dreißigstel im Depot
Das finde ich echt mutig…da habe ich nur ein dreißigstel im Depot
Durchsuchen
